Allergan Says Valeant Seeking Hearing on Shareholder Meeting

Allergan Inc. says Valeant Pharmaceuticals International Inc. and Pershing Square Capital Management want a judge in September to review demands that the maker of the Botox anti-wrinkle cream call a special shareholder meeting as part of Valeant’s $54 billion takeover bid.

Valeant and Pershing Square, a hedge fund run by Bill Ackman, are asking Delaware Chancery Judge Andre Bouchard to set a trial for Sept. 24 on whether they properly secured support of enough Allergan stockholders to force a meeting of investors to consider replacing a majority of the company’s directors, according to court filings.